Bhageria Industries Q2 FY22: Revenue ₹141 Cr, PAT ₹15 Cr
Q2 FY22 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #14 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Bhageria Industries Ltd Q2 FY22 key numbers
- Revenue
- Q2 FY22 Net Sales: Rs 141 crore, up 33.7% YoY from Rs 106 crore in Q2 FY21.
As stated in Bhageria Industries Ltd's Q2 FY22 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Bhageria Industries Ltd's Q2 FY22 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY22 Net Sales: Rs 141 crore, up 33.7% YoY from Rs 106 crore in Q2 FY21 (Page 5). Q2 FY22 EBITDA: Rs 26 Cr, up 7% YoY from Rs 25 Cr in Q2 FY21 - Q2 FY22 EBITDA Margin: 18.1%, down from 23.8% in Q2 FY21 - Q2 FY22 PAT: Rs 15 Cr, down 6.6% YoY from Rs 16 Cr in Q2 FY21 - Q2 FY22
From Bhageria Industries Ltd's Q2 FY22 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2 FY22 Net Sales: Rs 141 crore, up 33.7% YoY from Rs 106 crore in Q2 FY21 (Page 5).
- H1 FY22 Net Sales: Rs 254 crore, up 61.1% YoY from Rs 158 crore in H1 FY21 (Page 5).
- Chemical segment Q2 FY22 sales: Rs 134 crore versus Rs 100 crore in Q2 FY21 (Page 5).
2 more points from Bhageria Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bhageria Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Total planned capex of ~Rs. 130 crore funded through internal accruals.
- Specific capex allocations:
- Rs. 46 crore for backward integration (100% incurred).
- Rs. 34 crore for expansion in dye intermediates (100% incurred).
- Rs. 15 crore for manufacturing of pigment intermediates (90% incurred).
- Rs.
- Increase power capacity to 8,000 KW at existing facility to cater to increased capacities.
- Manufacture of sulphuric acid & derivatives, margin accretive products J-acid and Tobias acid.
- Exploring new intermediates products.
- Board approved acquisition of 51% equity shares of Bhageria & Jajodia Pharmaceuticals Pvt. Ltd., marking entry into pharma segment.
2 more points from Bhageria Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bhageria Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Bhageria Industries Ltd said on order book & pipeline — free account, 30 seconds.
Bhageria Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹453 Cr, net profit ₹58 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bhageria Industries's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bhageria Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bhageria Industries Ltd Q2 FY22 results?
Q2 FY22 Net Sales: Rs 141 crore, up 33.7% YoY from Rs 106 crore in Q2 FY21 (Page 5). Q2 FY22 EBITDA: Rs 26 Cr, up 7% YoY from Rs 25 Cr in Q2 FY21 - Q2 FY22 EBITDA Margin: 18.1%, down from 23.8% in Q2 FY21 - Q2 FY22 PAT: Rs 15 Cr, down 6.6% YoY from Rs 16 Cr in Q2 FY21 - Q2 FY22
What is Bhageria Industries Ltd share price analysis?
Bhageria Industries Ltd currently shows a neutral. The stock trades at a P/E of 19.7 with a market cap of ₹1,461 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bhageria Industries Ltd planning capital expenditure?
Total planned capex of ~Rs. 130 crore funded through internal accruals.
Keep Bhageria Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
